Kazuaki Takabe

17.9k total citations · 1 hit paper
398 papers, 12.6k citations indexed

About

Kazuaki Takabe is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kazuaki Takabe has authored 398 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Oncology, 170 papers in Molecular Biology and 116 papers in Cancer Research. Recurrent topics in Kazuaki Takabe's work include Sphingolipid Metabolism and Signaling (65 papers), Cancer Immunotherapy and Biomarkers (58 papers) and Ferroptosis and cancer prognosis (57 papers). Kazuaki Takabe is often cited by papers focused on Sphingolipid Metabolism and Signaling (65 papers), Cancer Immunotherapy and Biomarkers (58 papers) and Ferroptosis and cancer prognosis (57 papers). Kazuaki Takabe collaborates with scholars based in United States, Japan and Canada. Kazuaki Takabe's co-authors include Sarah Spiegel, Li Yan, Sheldon Milstien, Masayuki Nagahashi, Masanori Oshi, Itaru Endo, Yoshihisa Tokumaru, Omar M. Rashid, Nitai C. Hait and Eriko Katsuta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Kazuaki Takabe

380 papers receiving 12.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

“Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets

2008 580 citations Kazuaki Takabe, Sheldon Milstien et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuaki Takabe United States	60	7.0k	4.3k	2.8k	2.3k	2.1k	398	12.6k
Diether Lambrechts Belgium	53	6.3k 0.9×	3.9k 0.9×	2.8k 1.0×	2.1k 0.9×	1.8k 0.9×	296	14.4k
Keping Xie United States	71	11.0k 1.6×	5.5k 1.3×	5.4k 1.9×	1.4k 0.6×	2.0k 1.0×	210	17.2k
Daniel E. Johnson United States	46	8.4k 1.2×	4.3k 1.0×	2.3k 0.8×	1.5k 0.6×	2.2k 1.1×	133	13.6k
Ivan Bièche France	76	11.1k 1.6×	5.9k 1.3×	5.7k 2.0×	2.6k 1.1×	1.7k 0.8×	497	20.2k
Phillip A. Dennis United States	49	7.6k 1.1×	4.6k 1.1×	2.2k 0.8×	2.5k 1.1×	1.2k 0.6×	137	12.4k
Akira Nakagawara Japan	69	11.4k 1.6×	5.3k 1.2×	4.4k 1.6×	1.3k 0.6×	1.4k 0.7×	347	18.0k
David M. Jablons United States	61	6.9k 1.0×	4.8k 1.1×	2.0k 0.7×	5.2k 2.3×	1.5k 0.7×	273	14.2k
Joyce M. Slingerland United States	60	10.3k 1.5×	8.1k 1.9×	3.0k 1.1×	1.5k 0.6×	1.0k 0.5×	120	15.5k
Weiya Xia United States	56	12.4k 1.8×	8.0k 1.8×	3.8k 1.4×	1.8k 0.8×	2.4k 1.2×	114	18.0k
Dan Theodorescu United States	69	7.5k 1.1×	3.6k 0.8×	2.8k 1.0×	3.1k 1.4×	1.2k 0.6×	335	14.6k

Countries citing papers authored by Kazuaki Takabe

Since Specialization

Citations

This map shows the geographic impact of Kazuaki Takabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuaki Takabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuaki Takabe more than expected).

Fields of papers citing papers by Kazuaki Takabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuaki Takabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuaki Takabe. The network helps show where Kazuaki Takabe may publish in the future.

Co-authorship network of co-authors of Kazuaki Takabe

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuaki Takabe. A scholar is included among the top collaborators of Kazuaki Takabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuaki Takabe. Kazuaki Takabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takabe, Kazuaki, et al.. (2026). High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer. Annals of Surgical Oncology.

Oshi, Masanori, Farhad Ghasemi, Akimitsu Yamada, et al.. (2025). Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer. Annals of Surgical Oncology. 32(10). 7959–7969.

Benesch, Matthew G.K., et al.. (2024). Epidemiology of Adenosquamous Carcinomas. World Journal of Oncology. 15(3). 432–453. 2 indexed citations

Edge, Stephen B., et al.. (2023). Burnout in the female surgical trainee; is it time to consider a more global approach to tackle this issue?. SHILAP Revista de lepidopterología. 13. 100162–100162. 2 indexed citations

Takabe, Kazuaki, et al.. (2023). The Association of Human Cytomegalovirus Infection and Colorectal Cancer: A Clinical Analysis. World Journal of Oncology. 14(2). 119–124. 4 indexed citations

Wu, Rongrong, Masanori Oshi, Mariko Asaoka, et al.. (2023). Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer. Annals of Surgery. 278(4). 587–597. 24 indexed citations

Oshi, Masanori, et al.. (2023). Association of enhanced epithelial-mesenchymal transition signature with tumor microenvironment, angiogenesis, and survival in gastric cancer.. Journal of Clinical Oncology. 41(16_suppl). e16002–e16002. 1 indexed citations

Moro, Kazuki, Hiroshi Ichikawa, Yu Koyama, et al.. (2023). Oral Administration of Glucosylceramide Suppresses Tumor Growth by Affecting the Ceramide/Sphingosine-1-Phosphate Balance in Breast Cancer Tissue. World Journal of Oncology. 14(5). 430–437.

Oshi, Masanori, Shipra Gandhi, Fernando A. Angarita, et al.. (2021). A novel five-gene score to predict complete pathological response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.. PubMed Central. 11(7). 3611–3627. 10 indexed citations

10.

Oshi, Masanori, et al.. (2020). MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer. International Journal of Molecular Sciences. 21(21). 8127–8127. 85 indexed citations

11.

Yao, Song, Ting‐Yuan David Cheng, Ahmed Elkhanany, et al.. (2020). Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion. JNCI Journal of the National Cancer Institute. 113(8). 1036–1043. 59 indexed citations

12.

Aoki, Masayo, et al.. (2020). The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force‐Induced Abnormal Scars. Journal of Immunology Research. 2020(1). 7057195–7057195. 20 indexed citations

13.

Tsuchida, Junko, Masayuki Nagahashi, Masato Nakajima, et al.. (2020). Sphingosine Kinase 1 is Associated With Immune Cell–Related Gene Expressions in Human Breast Cancer. Journal of Surgical Research. 256. 645–656. 9 indexed citations

14.

Shimada, Yoshifumi, Masayuki Nagahashi, Hiroshi Ichikawa, et al.. (2019). SMAD4 alteration associates with invasive‐front pathological markers and poor prognosis in colorectal cancer. Histopathology. 74(6). 873–882. 34 indexed citations

15.

Yamada, Akimitsu, Masayuki Nagahashi, Tomoyoshi Aoyagi, et al.. (2018). ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. Molecular Cancer Research. 16(6). 1059–1070. 61 indexed citations

16.

Nagahashi, Masayuki, Akimitsu Yamada, Eriko Katsuta, et al.. (2018). Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis. Cancer Research. 78(7). 1713–1725. 165 indexed citations

17.

Yuza, Kizuki, Masato Nakajima, Masayuki Nagahashi, et al.. (2018). Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression. Journal of Surgical Research. 232. 186–194. 33 indexed citations

18.

Yamada, Akimitsu, Takashi Ishikawa, Ikuko Ota, et al.. (2013). High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival. Breast Cancer Research and Treatment. 137(3). 773–782. 98 indexed citations

19.

Nagahashi, Masayuki, Subramaniam Ramachandran, Eugene Y. Kim, et al.. (2012). Sphingosine-1-Phosphate Produced by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis. Cancer Research. 72(3). 726–735. 265 indexed citations

20.

Aoyagi, Tomoyoshi, Masayuki Nagahashi, Akimitsu Yamada, & Kazuaki Takabe. (2012). The Role of Sphingosine-1-Phosphate in Breast Cancer Tumor-Induced Lymphangiogenesis. Lymphatic Research and Biology. 10(3). 97–106. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact